Company News

Amhwa Biopharm Co., Ltd. passed the US FDA inspection without defects!

Good news! Amhwa Biology ProEnzy ™ enzyme cutting technology obtained the national invention patent

Recently, the ProEnzy™ enzymatic digestion technology for the preparation of small molecule sodium hyaluronate, namely "a method for the preparation of small molecule hyaluronate or its salt", was declared by Amhwa Biology. It has been officially authorized by the State Intellectual Property Office ......

Good news! Amhwa Biology ProEnzy ™ enzyme cutting technology obtained the national invention patent

Recently, the ProEnzy™ enzymatic digestion technology for the preparation of small molecule sodium hyaluronate, namely "a method for the preparation of small molecule hyaluronate or its salt", was declared by Amhwa Biology. It has been officially authorized by the State Intellectual Property Office ......

Amhwa Biology export qualification of EU API approved

Recently, after the review of the Shandong Provincial Drug Administration, Amhwa Biology officially approved the qualification of the Export of raw material drugs to the EU. As the second API supplier in China to master the extraction of sodium hyaluronate by biological fermentation, this approval m......

On May 19, 2017, Amhwa Biology received the DMF filing Registration Number confirmation letter from the US FDA

On May 19, 2017, Amhwa Biology received the DMF filing Registration Number confirmation letter from the US FDA, informing Amhwa Biology that it had obtained the DMF filing registration number 031799.

Amhwa Biology presents pharmaceutical grade products at the European Pharmaceutical Raw Materials Exhibition Trip to Barcelona

CPHI Barcelona was successfully held in Fira Barcelona Gran Via, Spain from 24 to 26 October 2023. As a high-profile global pharmaceutical event, this year's event builds on a legacy of excellence by bringing together suppliers, innovators and pharmaceutical professionals in a unique way, combining ......